🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#ASCO22 | June 3 | Education Session | Developmental Therapeutics "Tebentafusp for Uveal Melanoma" Panel Speaker: Melinda Yushak, MD, MPH #melsm ➡️ fal.cn/3pawg

… and an essay in the NYT. 7/ nytimes.com/2022/06/20/opi…

The ⁦Paulos Lab⁩ is VERY thrilled to welcome our #gamechanger postdoc fellow ⁦Dr.YayaTheScientist⁩ to ⁦Emory University⁩ ⁦Winship Cancer Institute of Emory University⁩!

‘Wolde ye bothe eate your cake, and haue your cake?’ -John Heywood, 1546 Uncoupling T-cell expansion from effector differentiation in cell-based immunotherapy pubmed.ncbi.nlm.nih.gov/24329803/

💥Less is more: @MeganMWyatt’s new manuscript in bioRxiv shows metabolically fit CAR T cells can be generated using fewer activation beads in Paulos Lab w/ Gregory Lesinski Jim Riley. Props Guillermo O. Rangel Rivera Hannah Knochelmann, MD PhD Michelle Nelson Aubrey Smith, PhD Winship Cancer Institute of Emory University

The best of the best of the best, herein!! Woot Dr.YayaTheScientist

Increased numbers of neutrophils and macrophages associated with cancer progression may be risk factors for anaphylaxis. jitc.bmj.com/content/10/12/…

Great work from Zihai Li, MD, PhD and lab. jitc.bmj.com/content/10/9/e…

CD40 agonism may circumvent a dysfunctional CD4 compartment to improve PD-1 blockade responsiveness, supporting a novel synergistic immunotherapeutic approach.jitc.bmj.com/content/10/12/…

CD40-activated B cells to the rescue! jitc.bmj.com/content/10/12/…

Set your life on fire. Seek those who fan your flames. -Rumi

We Paulos Lab honored to be #JITCTop10 for this coolio B cell ACT CD8 T cell paper. ;)

⭐️A must read!!! Congrats to Gregory Lesinski & team for stellar work in novel immunotherapy to impact #PancreaticCancer. Just out in JCI insight: insight.jci.org/articles/view/…. Society for Immunotherapy of Cancer The American Association of Immunologists (AAI) Winship Cancer Institute of Emory University

☀️A must read by our MSTP student Guillermo O. Rangel Rivera! The degree of T cell stemness differentially impacts the potency of adoptive cancer immunotherapy in a Lef-1 and Tcf-1 dependent manner. biorxiv.org/content/10.110…

If you're not using AI, you're falling behind. Here are 20 AI tools to future-proof yourself. Get more tools like this by signing up to Superhuman AI--the world’s biggest AI newsletter.

This! Please consider donating to our colleague in her time of need.

Excited to announce that this manuscript is officially out in the latest issue of JCI! Thanks again to all the coauthors and of course to my postdoc mentor Don Gibbons for his continual support! The model figure from these studies:

Newest preprint paper by our team (Gregory Lesinski & Paulos Lab) in biRxiv! Winship Cancer Institute of Emory University Society for Immunotherapy of Cancer Clinically relevant orthotopic pancreatic cancer models for adoptive T cell therapy biorxiv.org/content/10.110…

Check out Dr. Guillermo O. Rangel Rivera's new Cancer Research paper. We show that not all stem-like memory CD8 T cells are equal... Progressively enhancing stemness of adoptively transferred T cells with PI3Kδ blockade improves metabolism and anti-tumor immunity …rjournals-org.proxy.library.emory.edu/cancerres/arti…